Completion of SON-1010 (IL12-FHAB) monotherapy dose escalation in Phase 1 SB101 trial; Stable disease (SD) at four months post-initiation of ...

Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs.

Ted Pella's glass Tissue Floatation Water Bath has been developed using microprocessor controls and a modular design that has improved reliability and precision. The unit is low profile with a ...